Notice: Prescription Drug List (PDL): Triamcinolone acetonide
The purpose of this Notice of Intent to Amend is to notify that, as a result of consultation, Health Canada will revise the listing for Adrenocortical hormones on the Prescription Drug List (PDL) to exempt Triamcinolone acetonide.
- Publisher
- Health Canada
- Resources
- 2
- Catalogue metadata updated
- 2023-09-30
Data overview
- Formats
- HTML
- File languages
- English, French